Harmony Biosciences Holdings, Inc. HRMY
- WAKIX — Narcolepsy Approved
- WAKIX — Prader-Willi Syndrome Phase 3
- pitolisant — Multiple Sclerosis Preclinical
H3 receptors (1 companies · 3 programs)
Companies with an active program directed at H3 receptors.
Companies with an active program directed at H3 receptors.